Dow Down 0.48% Nasdaq Up 0.29%

CytRx Corporation (CYTR)

-NasdaqCM
2.99 Up 0.21(7.55%) May 31, 4:00PM EDT
|After Hours : 3.10 Up 0.11 (3.68%) May 31, 7:56PM EDT
Prev Close:2.78
Open:2.83
Bid:2.99 x 500
Ask:3.28 x 2500
1y Target Est:6.83
Beta:2.38013
Earnings Date:Aug 1 - Aug 5 (Est.)
Day's Range:2.83 - 3.28
52wk Range:1.55 - 4.29
Volume:2,408,739
Avg Vol (3m):858,997
Market Cap:199.61M
P/E (ttm):N/A
EPS (ttm):-0.85
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
CYTRUp 7.55%199.61M
LLYUp 0.05%79.18B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):1,855.93
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :-0.78
Quarterly EPS Est (Jun-16) :-0.20
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

CytRx Corporation operates as a biopharmaceutical research and development company specializing in oncology. The company’s product candidate is aldoxorubicin, which is in Phase III clinical trial as a therapy for patients with soft tissue sar... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback